“Intermediate Results of the Prospective Randomized Controlled Trial VOG-01: ‘Evaluation of the Efficacy of Neoadjuvant Combination Hormone Therapy in Premenopausal Patients With ER+ HER2- Breast Cancer’”. Voprosy Onkologii, vol. 68, no. 3, July 2022, pp. 354-61, https://doi.org/10.37469/0507-3758-2022-68-3-354-361.